These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 15190924

  • 21. Off-label marketing and the First Amendment.
    Boumil MM.
    N Engl J Med; 2013 Jan 10; 368(2):103-5. PubMed ID: 23234470
    [No Abstract] [Full Text] [Related]

  • 22. Drug risks and free speech--can Congress ban consumer drug ads?
    Shuchman M.
    N Engl J Med; 2007 May 31; 356(22):2236-9. PubMed ID: 17476002
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Off-label promotion: is FDA's final guidance on industry-supported scientific and educational programs enforceable?
    Bass IS, Kalb PE, Berenson BA.
    Food Drug Law J; 1998 May 31; 53(2):193-212. PubMed ID: 10346681
    [No Abstract] [Full Text] [Related]

  • 25. The FDA Export Reform and Enhancement Act of 1996: the FDA's new extraterritorial authority over labeling and promotional practices.
    Helmanis AM.
    Food Drug Law J; 1996 May 31; 51(4):631-5. PubMed ID: 11797732
    [No Abstract] [Full Text] [Related]

  • 26. Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement.
    Asamoah AK.
    Food Drug Law J; 2006 May 31; 61(2):385-418. PubMed ID: 16903035
    [No Abstract] [Full Text] [Related]

  • 27. Education or promotion?: Industry-sponsored continuing medical education (CME) as a center for the core/commercial speech debate.
    Chen P, Paul, Weiss, Rifkind, Wharton & Garrison LLP, New York, NY, USA.
    Food Drug Law J; 2003 May 31; 58(3):473-509. PubMed ID: 14626981
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Promoting functional foods and nutraceuticals on the Internet.
    Taylor SE, Feld HJ.
    Food Drug Law J; 1999 May 31; 54(3):423-51. PubMed ID: 11797707
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Health related claims, the market for information, and the first amendment.
    Beales JH.
    Health Matrix Clevel; 2011 May 31; 21(1):7-30. PubMed ID: 21847896
    [No Abstract] [Full Text] [Related]

  • 37. Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem.
    Teufel AT.
    J Contemp Health Law Policy; 2006 May 31; 22(2):383-408. PubMed ID: 17117702
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Trying times at the FDA--the challenge of ensuring the safety of imported pharmaceuticals.
    Schweitzer SO.
    N Engl J Med; 2008 Apr 24; 358(17):1773-7. PubMed ID: 18434648
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.